Daré Bioscience, Inc. (NASDAQ:DARE) Q1 2024 Earnings Call Transcript May 14, 2024
Daré Bioscience, Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $-0.06.
Operator: Welcome to the conference call hosted by Daré Bioscience to review the company’s First Quarter Financial Results and to provide the General Business Update. This call is being recorded. My name is Alex and I will be your operator for today. With us today from Daré are Sabrina Martucci...
